While surveillance data from 2024 shows an encouraging reduction in HIV transmissions1, more needs to be done to meet the …
Kimberly-Clark has agreed to acquire Johnson & Johnson (J&J) consumer health spinout Kenvue for $48.7bn. One of America’s largest consumer health …
The US Food and Drug Administration (FDA) has approved UCB’s Kygevvi (doxecitine and doxribtimine) to treat genetic mitochondrial disease, thymidine …
Eli Lilly and Company has outlined plans to develop a $3bn manufacturing facility in Katwijk, situated in the Leiden Bio …
According to Cancer Research UK, prostate cancer is the most common cancer among men in the UK, representing 28% of …
According to Cancer Research UK, prostate cancer is the most common cancer among men in the UK, representing 28% of …
Alvotech’s inflammation-targeting biosimilar AVT05 has been rejected by the U.S. Food and Drug Administration (FDA) because of issues with the …
Pfizer has followed through on its threats, filing a lawsuit against both Metsera and Novo Nordisk during a M&A bidding …
18 October 2025 marked the presentation of the highly anticipated OptiTROP-Breast02 trial at the 2025 European Society for Medical Oncology …
On 18 October 2025 at the European Society of Medical Oncology, held in Berlin, Germany, from 17 to 21 October, …
South Korean biotechnology company IntoCell has announced a memorandum of understanding (MoU) with US-based contract development and manufacturing organisation (CDMO) …
4D Molecular Therapeutics (4DMT) has announced an exclusive licence agreement with Otsuka Pharmaceutical to develop and market 4D-150, a treatment …
Sensei Biotherapeutics is set to abandon its sole clinical-stage asset solnerstotug as it prepares to cut its workforce and consider …
Epioxa by Glaukos Corp received US Food and Drug Administration (FDA) approval on 20 October as the first and only …
Every year, millions of disposable gowns end up in medical waste incinerators. But a new generation of sustainable textiles is …
